Anthony Fernando

On October 10th I'm diving deeper into what makes MedTech startup projects unique and difficult to manage with traditional methodology, as well as sharing my tips for avoiding the most common pitfalls in MedTech product development.

30

A Common Pitfall for MedTech / Medical device manufacturing Companies: 🚫 Mistake: Investing heavily in a product without customer feedback. 🚫 Risk: Channeling resources into development without a deep understanding of the target market, including cultural and societal norms. 📉 It's a frequent, costly error driven by arrogance and preallocated capital. ✨ Smart Strategy: Start with your MVP (Minimum Viable Product). 🌱 Why Gradual Growth? The most successful companies grow gradually because they take time to tailor their products to the markets they serve. Do not waste your time and efforts. Be quick to go to market but do your HW. Are you in Sales or Marketing and Part of the medtech/medical device manufacturing industry? Join our group! https://lnkd.in/g-EYhbSd #medicaldevice #medtechsales #medicaldevicemanufacturing #medicalsales #b2bsales #healthtech

12

2024: The year we transformed cardiac imaging from a complex procedure to an accessible, life-changing technology. When we introduced ECG-less cardiac CT on the Revolution Apex Platform, we weren't just launching a product - we were reimagining what's possible in medical imaging. Imagine performing a cardiac CT without the traditional ECG trace: that's not a dream anymore, that's our new reality. Looking ahead to 2025: Our commitment remains unwavering. We'll continue advancing CT technology accessibility, focusing on cardiac imaging and AI-driven workflows. The Revolution platform isn't just about technological excellence - it's about creating tools that help healthcare professionals deliver extraordinary patient care. To every radiologist, technologist, and healthcare professional pushing boundaries: your challenges inspire our innovation. #Revolution #ComputedTomography #GEHealthCare #LinkedInRewind #2024wrapped

41

1 Comment

Medtech capital raising: a summary of what I'm reading, hearing, and seeing. Would love to hear your opinion. Reading There’s cautious optimism. Headlines are starting to reflect a turning point, as highlighted in the Financing Outlook article in the latest issue of The Lens. Hearing In my conversations with Medtech venture investors, I’m hearing a consistent message: confidence is growing, though cautiously. Momentum is building, and we’ll likely see an increase in capital deployment. Seeing (most important) The most compelling indicator isn’t just what I’m reading or hearing—it’s what I’m seeing. Investors are showing up in force to look at deals. The sheer volume and quality of investors and strategics attending LSI USA '25 point to a strong appetite for Medtech investing and dealmaking over the next year. Here’s a small snapshot of the 200 investors & strategics already committed to our next event (pacing for well over 400 total). If you haven’t secured your spot, now’s the time. What is your outlook on the capital raising outlook for the next 12 months?

99

10 Comments

Getting amazing contract manufacturing partners is everything, but navigating the RFQ process is hard. Learn how to ace this process in the new pod episode

35

5 Comments

As Kimberly Powell puts it - Generative AI is poised to impact healthcare more profoundly than ANY other area of life. Everything from accelerating drug discovery to enhancing patient diagnostics and postoperative care is on the table. The only roadblock in front of us is the speed and efficiency with which we can implement AI on scale. Could Nvidia be the answer to these teething issues? #AIHealthcare #Healthcare #NvidiaAI #GenerativeAI #MedicalInnovation

2

🏥 Transforming Healthcare with Biobeat's Hospital-at-Home Solution 🏥 Hospital-at-Home programs, supported by advanced Remote Monitoring (RPM) tools like Biobeat's innovative solution, are proven to be safer, more cost-effective, and more efficient than traditional hospital care. Our Hospital-at-Home solution offers comprehensive monitoring of 13 medical vital signs, backed by FDA and CE approvals. Leveraging advanced health-AI platforms, Biobeat enhances patient outcomes with real-time early warning scores and data-driven decision support. These innovations ensure Hospital-at-Home programs can deliver hospital-level care, reduce complications, lower costs, and improve overall patient satisfaction. Our devices are utilized by Hospital-at-Home program providers like Best Buy Health, who have integrated Biobeat’s platform to improve continuous monitoring for chronic disease management in both inpatient and outpatient settings. Dive into this insightful blog to learn more about continuous monitoring in Hospital-at-Home programs: https://lnkd.in/etvPfryZ To learn more about Biobeat’s offerings click here: https://www.bio-beat.com/ #HealthcareInnovation #RemotePatientMonitoring #HospitalAtHome #Biobeat #bestbuyhealth #PatientCare #HealthTech #MedicalDevices

35

2 Comments

Sirona Medical took a novel approach to reimagining diagnostic radiology. It's an approach I believe we will see future software companies replicate across the various specialties in medicine. First, they built, from the ground up, an "Epic" like operating system (RadOS) for diagnostic radiology, all in one unified cloud native platform. One system, one service provider...eliminating the need for servers, hardware, etc. This also eliminates the need for radiologists to move in and out of countless different software platforms to accomplish the day to day tasks associated with practicing medicine. They then built assistive AI programs into system, making physicians faster, and more effective. And finally, they allowed top 3rd party AI vendors to build the kind of diagnostic AI programs on top of their platform, that are the future product that radiology will provide. This is the path less traveled for sure. It's expensive, and takes a considerable amount of time. But the impact these types of platforms will have on physicians, patients, and the system as a whole is profound. I believe strongly that what Sirona Medical has done will revolutionize this space. Over the next couple weeks, I will post some additional clips to further inform the market on why what they have done is so unique...and just how transformative this technology will be. In the interim, episode 46 of The Bleeding Edge of Digital Health Podcast is now up for viewing on all the major podcast directories, and our YouTube channel (links in comments). Thank you Cameron Andrews for joining on the show, and sharing the incredible tech you and your team have built! Bill Corsten Greg Stock David Paik Kathryn Kovalenko Aidan Andrews Raghavendra Nyamagoudar Nathan Ayers Chris Calder Jon Gallez Francisco Gimenez Perry Kaneriya, MD, MBA Patrice JC Nedelec 🇫🇷🇺🇸🇺🇦 Daniel C. Liem Samir Mehta Kaitlin Daugherty Mark D. Longo, Ph.D. Mike McCormick Ryan Dougherty Fred Ong Tanner Trombly Vijay Yeluri Adam Prater Alex Mc Vey #radiology #medtech #digitalhealth

58

8 Comments

Very interesting article on enabling technologies in Orthopedics... the proliferation (arms race) of Robotics (big and small), AR, AI and other technologies will have some BIG winners and a lot of "whatever happened to...". My good friend Sharat Kusuma, MD, FAAOS and Zimmer Biomet Chief Innovation Officer Nitin G. are both interviewed. Interesting perspective around the potential improvement (needs study) for lower volume Surgeons who typically are working in institutions who are less apt to purchase or ASC where any additional cost or time is less likely to be considered. https://lnkd.in/ggBhHQWH #vestiaconsulting #orthopedics #orthopedicsurgery Vestia Personal Wealth Advisors #DoctorCFO #wealththatmatters

8

2 Comments

The success of the MedTech industry in Israel is inherently tied to the mentality of its founders in 1948, that they could make Something from Nothing, as I discuss in this clip. We had a lot of fun reminiscing about the MedTech Mission to Israel with Joe Mullings and Nicole Ager of Dragonfly - A TMG Company, along with Adam Rosenwach, Avi Fischer, David Hochman and Tal Wenderow. https://lnkd.in/e5spq4SM

49

2 Comments

Tune in to the most recent episode of Funding Medtech Podcast to listen to Josh Nickols, PhD and Rich Mazzola discuss the details (the network, investment thesis, check size, etc.) of Boomerang Ventures. Links to the podcast, monthly newsletter, and website are in the comments below! Follow Project Medtech on LinkedIn for more great content or visit our website #medicaldevices #startup #medtech #projectmedtech #innovation #medicaldevice #podcast #strategy

21

5 Comments

After multiple years of data collection, our study on the impact of engineering outreach efforts was published in the PLOS ONE journal. The findings offer an intriguing assessment of how collaborating with science-focused digital content creators like Mark Rober and Derek Muller (Veritasium) and engaging with the wider maker community can amplify the influence of a particular field of research. Whether you're in industry or academia, the goal of this publication is to help bridge the gap by sharing a framework for ways to better leverage novel academic research into applications in industry. https://lnkd.in/dpR6KjSF

36

2 Comments

Congratulations to Mendaera on Closing a $73M Series B! With its first-of-its-kind platform, Mendaera, Inc. is pioneering a new category in medical robotics Mendaera, Inc., a Silicon Valley-based #MedTech #startup developing a handheld robotic interventional platform, announced today the close of $73 million in Series B funding led by Threshold Ventures, with participation from investors including Lux Capital, PFM Health Sciences, and Fred Moll (founder of Intuitive Surgical and Auris Health). The financing will further Mendaera’s efforts to scale robotics and AI across mainstream medical procedures. Mendaera is pioneering a new category in #medicalrobotics, making advanced technologies readily available for these foundational everyday procedures. Its handheld interventional platform includes robotics, #AI, real-time imaging, and virtual connectivity, and is designed to be accessible across specialties and sites of service to empower providers and systems to better meet the growing demand for needle-based interventions. By better distributing care for this ubiquitous yet often-overlooked category of procedures, Mendaera aims to improve hundreds of millions of patient encounters per year and drive systemwide efficiencies. “Traditional #surgicalrobots have established footing in the operating room,” said Josh DeFonzo, Founder and CEO of Mendaera. “But robotics and AI have evolved to a point where we can deliver broader benefits across all parts of the healthcare system and enable higher standards of care for more patients. We believe that our technology will allow healthcare systems and providers to provision medical procedures at scale – enhancing patient experience, increasing access to high-quality care, reducing overall cost, and improving healthcare provider satisfaction.” “Mendaera has the unique ability to improve the patient experience and make high-quality care widely accessible,” said Emily Melton, Founder and Managing Partner at Threshold Ventures. “Amidst rising healthcare costs and labor shortages impacting quality and affordability, it is imperative to harness advanced technology to revolutionize healthcare delivery. We are thrilled to join forces with the dynamic Mendaera team, comprising the most innovative and accomplished leaders in medical robotics and software.” Mendaera will utilize the new funding to complete development of its robotic technology, accelerate development of its AI and connectivity capabilities, and begin clinical introduction of its platform. Earlier this year, Mendaera announced that it had acquired the telepresence technology of Avail Medsystems to expand its portfolio to include virtual connectivity. In 2023, Mendaera announced a commercial agreement with the point-of-care ultrasound company Butterfly Network, Inc.

16

1 Comment

I love all the folks over at Informa and am honored to present a webinar with Omar Ford called Beyond Human Limits: The Rising Role of Robots in Surgery We'll be chatting about surgical robotics, where it's come from, where it's going, and how AI may shape future applications. Register for free with the link below https://lnkd.in/eBZEiyPj #AI #INFORMA #SURGICALROBOTS #MEDTECH

9

The Future of Artificial Intelligence in Orthopedics 🔑 The FDA witnessed a 39% increase in AI/ML submissions from 2019 to 2020. 🔑 AI is showing promise in reviewing implanted devices before revision surgery. A study in Arthroplasty found a deep-learning model accurately predicted knee implant types 99% of the time. This could save time in pre-op planning and improve procedure efficiency. 🔗 https://lnkd.in/g_wGp2kz #AI #ArtificialIntelligence #healthcare #ImagingData #MedicalDevices #orthopedics #radiology #RevisionSurgery

5

1 Comment

This upcoming Friday I will have my Year in Review - 2024 and I will discuss the evolving models in medtech that support the critical development of emerging technologies and the ability to bring those technologies to patients via acquisition, rollup into private equity, or entry into the public markets. One of those successful models is Shifamed that has developed a fascinating and successful playbook. Amr Salahieh and I recently discussed the unique structure of Shifamed companies and the benefits to the market.

98

5 Comments